Performance
-
1W
-
1M
+0.83%
3M
+187.47%
6M
+96.63%
YTD
+95.12%
1Y
Profile
Ambrx Biopharma Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing antibody drug conjugates (ADCs) and other engineered therapies to modulate the immune system. It focuses on portfolio of clinical and preclinical programs designed to optimize efficacy and safety in multiple cancer indications, including ARX517, its proprietary antibody-drug conjugate (ADC) targeting the prostate-specific membrane antigen (PSMA) and ARX788, its proprietary ADC targeting HER2. The company also has preclinical and clinical collaborations with multiple partners on drug candidates using Ambrx technology. The company was incorporated in 2003 and is headquartered in La Jolla, California.
Investment Analysis Report: AMAM
Overview
AMAM is a company operating in the Health Technology sector, specifically in the Biotechnology industry. The company has a market capitalization of $1,757,541,833. In this report, we will conduct a comprehensive analysis of AMAM's financial statements over the past three years, focusing on the Balance Sh...
Technical Analysis of AMAM 2024-03-01
Overview:
In the last 5 trading days, the stock price of AMAM has shown a relatively stable trend with minor fluctuations. Various technical indicators across trend, momentum, volatility, and volume have been analyzed to provide insights into the possible future stock price movement.
Trend Analysis:
- Moving Averages (MA): The 5-day Moving Averag...
Recent News & Updates
- 2024-03-06 13:20
Ambrx Shareholders Approve Acquisition by Johnson & Johnson(GlobeNewswire)
- 2024-03-06 00:20
Ambrx Shareholders Approve Acquisition by Johnson & Johnson(Globenewswire)
- 2024-02-19 20:40
- 2024-02-12 00:43
- 2024-02-07 23:26
- 2024-01-29 10:02
- 2024-01-25 02:23
- 2024-01-24 19:03
- 2024-01-23 01:45
- 2024-01-16 21:42
- 2024-01-10 02:07
- 2024-01-08 21:25
- 2024-01-08 07:35
Ambrx Announces Sale to Johnson & Johnson(GlobeNewswire)
- 2024-01-08 01:51
- 2024-01-07 23:22
Why Is Ambrx Biopharma (AMAM) Stock Up 100% Today?(Investorplace)
- 2024-01-07 22:35
- 2024-01-07 19:08
- 2024-01-07 18:35
Ambrx Announces Sale to Johnson & Johnson(Globenewswire)
- 2024-01-07 18:30
- 2023-12-14 08:48
Ambrx to be Added to the NASDAQ Biotechnology Index (NBI)(GlobeNewswire)
- 2023-12-13 19:48
Ambrx to be Added to the NASDAQ Biotechnology Index (NBI)(globenewswire)
- 2023-11-28 08:19
- 2023-11-27 19:19
- 2023-10-25 22:32
5 Best Performing NASDAQ Stocks in 2023(insidermonkey)
- 2023-10-23 08:00
- 2023-10-22 20:00
- 2023-10-16 07:56
- 2023-10-15 19:56
- 2023-09-30 23:00
Top Stocks for October 2023(investopedia)
- 2023-09-25 20:30
Page 1 of 4
previousnext